These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 34222016)

  • 21. DNA cleavage within the MLL breakpoint cluster region is a specific event which occurs as part of higher-order chromatin fragmentation during the initial stages of apoptosis.
    Stanulla M; Wang J; Chervinsky DS; Thandla S; Aplan PD
    Mol Cell Biol; 1997 Jul; 17(7):4070-9. PubMed ID: 9199342
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gene rearrangements in bone marrow cells of patients with acute myelogenous leukemia.
    Schmetzer HM; Braun S; Wiesner D; Duell T; Gerhartz HH; Mittermueller J
    Acta Haematol; 2000; 103(3):125-34. PubMed ID: 10940650
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of apoptotic nuclease caspase-activated DNase in etoposide-induced treatment-related acute myelogenous leukemia.
    Hars ES; Lyu YL; Lin CP; Liu LF
    Cancer Res; 2006 Sep; 66(18):8975-9. PubMed ID: 16982737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chlorpyrifos Induces MLL Translocations Through Caspase 3-Dependent Genomic Instability and Topoisomerase II Inhibition in Human Fetal Liver Hematopoietic Stem Cells.
    Lu C; Liu X; Liu C; Wang J; Li C; Liu Q; Li Y; Li S; Sun S; Yan J; Shao J
    Toxicol Sci; 2015 Oct; 147(2):588-606. PubMed ID: 26198043
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pro-B-cell to pre-B-cell development in B-lineage acute lymphoblastic leukemia expressing the MLL/AF4 fusion protein.
    Bertrand FE; Vogtenhuber C; Shah N; LeBien TW
    Blood; 2001 Dec; 98(12):3398-405. PubMed ID: 11719380
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular analysis of 13 cases of MLL/11q23 secondary acute leukemia and identification of topoisomerase II consensus-binding sequences near the chromosomal breakpoint of a secondary leukemia with the t(4;11).
    Domer PH; Head DR; Renganathan N; Raimondi SC; Yang E; Atlas M
    Leukemia; 1995 Aug; 9(8):1305-12. PubMed ID: 7643617
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insights into the cellular origin and etiology of the infant pro-B acute lymphoblastic leukemia with MLL-AF4 rearrangement.
    Bueno C; Montes R; Catalina P; Rodríguez R; Menendez P
    Leukemia; 2011 Mar; 25(3):400-10. PubMed ID: 21135858
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Zinc Finger Nuclease induced DNA double stranded breaks and rearrangements in MLL.
    Do TU; Ho B; Shih SJ; Vaughan A
    Mutat Res; 2012 Dec; 740(1-2):34-42. PubMed ID: 23291497
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evi-1 is a transcriptional target of mixed-lineage leukemia oncoproteins in hematopoietic stem cells.
    Arai S; Yoshimi A; Shimabe M; Ichikawa M; Nakagawa M; Imai Y; Goyama S; Kurokawa M
    Blood; 2011 Jun; 117(23):6304-14. PubMed ID: 21190993
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dietary flavonoids induce MLL translocations in primary human CD34+ cells.
    Barjesteh van Waalwijk van Doorn-Khosrovani S; Janssen J; Maas LM; Godschalk RW; Nijhuis JG; van Schooten FJ
    Carcinogenesis; 2007 Aug; 28(8):1703-9. PubMed ID: 17468513
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Site-specific DNA cleavage within the MLL breakpoint cluster region induced by topoisomerase II inhibitors.
    Aplan PD; Chervinsky DS; Stanulla M; Burhans WC
    Blood; 1996 Apr; 87(7):2649-58. PubMed ID: 8639880
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phenotypic Analysis of ATM Protein Kinase in DNA Double-Strand Break Formation and Repair.
    Mian E; Wiesmüller L
    Methods Mol Biol; 2017; 1599():317-334. PubMed ID: 28477129
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rearrangements of the MLL gene in therapy-related acute myeloid leukemia in patients previously treated with agents targeting DNA-topoisomerase II.
    Super HJ; McCabe NR; Thirman MJ; Larson RA; Le Beau MM; Pedersen-Bjergaard J; Philip P; Diaz MO; Rowley JD
    Blood; 1993 Dec; 82(12):3705-11. PubMed ID: 8260707
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Etoposide and illegitimate DNA double-strand break repair in the generation of MLL translocations: new insights and new questions.
    Sung PA; Libura J; Richardson C
    DNA Repair (Amst); 2006 Sep; 5(9-10):1109-18. PubMed ID: 16809075
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bortezomib suppresses self-renewal and leukemogenesis of leukemia stem cell by NF-ĸB-dependent inhibition of CDK6 in MLL-rearranged myeloid leukemia.
    Zhou B; Qin Y; Zhou J; Ruan J; Xiong F; Dong J; Huang X; Yu Z; Gao S
    J Cell Mol Med; 2021 Mar; 25(6):3124-3135. PubMed ID: 33599085
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preferential induction of MLL(Mixed Lineage Leukemia) rearrangements in human lymphocyte cultures treated with etoposide.
    Brassesco MS; Montaldi AP; Sakamoto-Hojo ET
    Genet Mol Biol; 2009 Jan; 32(1):144-50. PubMed ID: 21637660
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rearrangement of the MLL gene in acute lymphoblastic and acute myeloid leukemias with 11q23 chromosomal translocations.
    Thirman MJ; Gill HJ; Burnett RC; Mbangkollo D; McCabe NR; Kobayashi H; Ziemin-van der Poel S; Kaneko Y; Morgan R; Sandberg AA
    N Engl J Med; 1993 Sep; 329(13):909-14. PubMed ID: 8361504
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Double and single mixed-lineage leukemia-rearranged subclones in pediatric acute myeloid leukemia: a case report.
    McGrath M; Smink G
    J Med Case Rep; 2021 May; 15(1):228. PubMed ID: 33957966
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antitumor effect of baicalin from the Scutellaria baicalensis radix extract in B-acute lymphoblastic leukemia with different chromosomal rearrangements.
    Orzechowska BU; Wróbel G; Turlej E; Jatczak B; Sochocka M; Chaber R
    Int Immunopharmacol; 2020 Feb; 79():106114. PubMed ID: 31881375
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The MLL recombinome of acute leukemias in 2013.
    Meyer C; Hofmann J; Burmeister T; Gröger D; Park TS; Emerenciano M; Pombo de Oliveira M; Renneville A; Villarese P; Macintyre E; Cavé H; Clappier E; Mass-Malo K; Zuna J; Trka J; De Braekeleer E; De Braekeleer M; Oh SH; Tsaur G; Fechina L; van der Velden VH; van Dongen JJ; Delabesse E; Binato R; Silva ML; Kustanovich A; Aleinikova O; Harris MH; Lund-Aho T; Juvonen V; Heidenreich O; Vormoor J; Choi WW; Jarosova M; Kolenova A; Bueno C; Menendez P; Wehner S; Eckert C; Talmant P; Tondeur S; Lippert E; Launay E; Henry C; Ballerini P; Lapillone H; Callanan MB; Cayuela JM; Herbaux C; Cazzaniga G; Kakadiya PM; Bohlander S; Ahlmann M; Choi JR; Gameiro P; Lee DS; Krauter J; Cornillet-Lefebvre P; Te Kronnie G; Schäfer BW; Kubetzko S; Alonso CN; zur Stadt U; Sutton R; Venn NC; Izraeli S; Trakhtenbrot L; Madsen HO; Archer P; Hancock J; Cerveira N; Teixeira MR; Lo Nigro L; Möricke A; Stanulla M; Schrappe M; Sedék L; Szczepański T; Zwaan CM; Coenen EA; van den Heuvel-Eibrink MM; Strehl S; Dworzak M; Panzer-Grümayer R; Dingermann T; Klingebiel T; Marschalek R
    Leukemia; 2013 Nov; 27(11):2165-76. PubMed ID: 23628958
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.